Treatment of type 1 diabetes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9271984
APP PUB NO 20130131066A1
SERIAL NO

13703147

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to triazine derivatives of formula (I) for their use in the treatment of type 1 diabetes mellitus, and to compositions comprising said triazine derivatives.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
POXELIMMEUBLE LE SUNWAY 259/261 AVENUE JEAN JAURÈS LYON 69007

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bolze, Sébastien Massieux, FR 13 7
Cravo, Daniel Montesson, FR 33 169
Fouqueray, Pascale Sins, CH 9 5
Hallakou-Bozec, Sophie Montrouge, FR 19 64

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00